Showing 1,441 - 1,460 results of 109,543 for search '(( a point decrease ) OR ( 5 ((((we decrease) OR (teer decrease))) OR (a decrease)) ))', query time: 1.88s Refine Results
  1. 1441

    Active spread of mtDNAs in the network can increase and decrease cell-to-cell variability from cell divisions. by Robert C. Glastad (10692277)

    Published 2023
    “…Rows show different values of initial mutant proportion, with <i>h</i> = 0.1 in the top row and <i>h</i> = 0.5 in the bottom row. The three columns for each panel give decreasing network heterogeneity, expressed via different seed numbers, 4, 16 and 64 (more seed points give a more homogeneous network). …”
  2. 1442
  3. 1443
  4. 1444
  5. 1445

    Macroalgae Decrease Growth and Alter Microbial Community Structure of the Reef-Building Coral, <em>Porites astreoides</em> by Rebecca Vega Thurber (41633)

    Published 2012
    “…To determine if macroalgae alter the coral microbiome, we conducted a field-based experiment in which the coral <em>Porites astreoides</em> was placed in competition with five species of macroalgae. …”
  6. 1446
  7. 1447
  8. 1448
  9. 1449

    Nef Decreases HIV-1 Sensitivity to Neutralizing Antibodies that Target the Membrane-proximal External Region of TMgp41 by Rachel P.J. Lai (193116)

    Published 2011
    “…While exploring the mechanism by which Nef increases the infectivity of cell-free virions, we investigated a functional link between Nef and Env. …”
  10. 1450

    IFN-β mRNA induction but IFN protein decrease in all mammalian cells upon ONNV infection. by Susanne E. Biesold (194461)

    Published 2011
    “…<p>(A) IFN-β mRNA induction was measured by species-specific real-time RT-PCR at time points 0, 8 and 24 hpi and correlated to the amount of relative ONNV genome equivalents in PCR units per ml. …”
  11. 1451

    Rac1 activity decreases in the presence of DECMA-1 and E-cadherin:Fc in 3-D cell aggregates. by Khameeka N. Kitt (227731)

    Published 2011
    “…<p>3-D MDCK cell aggregates were incubated with 10 µg/ml of DECMA-1 monovalent Fab' fragments (A), or 10 µg/ml of purified E-cadherin:Fc extracellular domain (E), or 10 µg/ml of Fc protein (I) for the indicated times. …”
  12. 1452
  13. 1453
  14. 1454

    Data_Sheet_2_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

    Published 2021
    “…Selective motor control (SMC) was assessed on a 5-point scale for the children with SCP. First, the anthropometrics, strength, and muscle size parameters were compared between the cohorts. …”
  15. 1455

    Data_Sheet_1_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

    Published 2021
    “…Selective motor control (SMC) was assessed on a 5-point scale for the children with SCP. First, the anthropometrics, strength, and muscle size parameters were compared between the cohorts. …”
  16. 1456
  17. 1457
  18. 1458

    Decreasing ShcA expression enhances TGF-β-induced Smad signaling. by Baby Periyanayaki Muthusamy (838234)

    Published 2015
    “…Note the enhanced basal pSmad3 or pSmad2 levels in cells transfected with ShcA siRNA. ShcA immunoblotting reveals decreased ShcA levels in cells transfected with ShcA siRNA, and GAPDH immunoblotting serves as loading control. …”
  19. 1459

    Decreased MCM2-6 in Drosophila S2 Cells Does Not Generate Significant DNA Damage or Cause a Marked Increase in Sensitivity to Replication Interference by Isabelle Crevel (119003)

    Published 2011
    “…<div><p>A reduction in the level of some MCM proteins in human cancer cells (MCM5 in U20S cells or MCM3 in Hela cells) causes a rapid increase in the level of DNA damage under normal conditions of cell proliferation and a loss of viability when the cells are subjected to replication interference. …”
  20. 1460

    Decreased antihyperglycemic drug use driven by high out-of-pocket costs despite Medicare coverage gap closure by Mugdha Gokhale (8676201)

    Published 2020
    “…<a><b>Objectives</b></a>: <a>Using the 2016 Medicare part D coverage gap as an example, we explored effects of increased out-of-pocket costs on adherence to branded </a>dipeptidyl peptidase-4 inhibitors (DPP-4i) in patients without financial subsidies, relative to subsidized patients who do not experience increased spending during the gap. …”